Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Colorectal Cancer Epidemiology and Screening in 2025

UCSF School of Medicine

S. Gupta

Early-Onset CRC: Epidemiology, Risk Factors, and Clinical Presentati…

Ibrahim Sahin

The Reasons We Get Colorectal Cancer and Why It’s So Common

James Church

The Role of Microbiome in Colorectal Cancer

Benjamin Weinberg

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

48 Hours in the Life of Receiving a Diagnostic Colonoscopy

UCI Health

A. Dua

Year in Review 2024 - Colorectal Cancer

Oncology 2024 Year in Review

R. Kim, T. Biachi

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

ASCO® GI 2025 Insights: Ph3 BREAKWATER Study - Encorafenib + Cetuxim…

Insights from 2025 ASCO® GI Annual Meeting

S. Kopetz

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

ASCO® GI 2025 Insights: CheckMate 8HW - First Results of Nivo + Ipi …

Insights from 2025 ASCO® GI Annual Meeting

T. André

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

ASCO® GI 2025 Summary: mCRC Case-Based Discussion - Lessons Learned

Insights from 2025 ASCO® GI Annual Meeting

R. Mehta, M. Shah

Rising Trends of Colorectal Cancer Among Millennials

Dr. Iris Gorfinkel

I. Gorfinkel

ASCO® GI 2025 Insights: Trifluridine/Tipiracil vs. Placebo in Patien…

Insights from 2025 ASCO® GI Annual Meeting

H. Bando

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Anal Cancer: Risk Factors and Prevention

GRACE

P. Romesser

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino